Eton Pharmaceuticals, Inc. (ETON) vs GH Research PLC (GHRS)
A side-by-side comparison of Eton Pharmaceuticals, Inc. and GH Research PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ETON
Eton Pharmaceuticals, Inc.
$54.67HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
GHRS
GH Research PLC
$21.77HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — ETON vs GHRS
growth of $100 · dividends reinvested · last 5yETON +814.8% (+55.7%/yr)GHRS +15.2% (+2.9%/yr)ETON compounded faster over this window
Log scale — wide-divergence pair
ETON GHRS
ETON vs GHRS: by the numbers
- •ETON is the larger company ($1.50B vs $1.49B market cap).
- •ETON is profitable (12.02% net margin) while GHRS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ETON | GHRS |
|---|---|---|
| P/E ratio | 142.15 | N/A |
| Forward P/E | 50.27 | N/A |
| P/S ratio | 14.18 | N/A |
| P/B ratio | 32.15 | 4.15 |
| EV / EBITDA | 71.92 | N/A |
| FCF yield | 0.98% | N/A |
Profitability
| Metric | ETON | GHRS |
|---|---|---|
| Gross margin | 57.87% | 0.00% |
| Operating margin | 0.09% | 0.00% |
| Net margin | 12.02% | 0.00% |
| ROE | 27.24% | -17.32% |
| ROIC | 20.41% | -19.87% |
Growth (annualized)
| Metric | ETON | GHRS |
|---|---|---|
| Revenue CAGR (5Y) | 47.98% | N/A |
| Total return CAGR (5Y) | 63.04% | 0.52% |
Frequently asked
- Is ETON or GHRS more profitable?
- ETON runs the higher net margin — ETON at 12.02% versus GHRS at 0.00%.
- How have ETON and GHRS total returns compared?
- Over the past 5 years, ETON delivered 63.04% and GHRS delivered 0.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eton Pharmaceuticals P/E ratioEton Pharmaceuticals ROEGH Research ROEEton Pharmaceuticals operating marginGH Research operating marginEton Pharmaceuticals revenue growthGH Research revenue growthEton Pharmaceuticals free cash flowGH Research free cash flow
Eton Pharmaceuticals & GH Research appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.